Battery Raw Materials
Battery Raw Materials market is segmented by region (country), players, by Type and by Applicatio ... Read More
Global and United States Crohn’s Disease Therapeutics Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Crohn’s Disease Therapeutics Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Crohn’s Disease Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Crohn’s Disease Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Crohn’s Disease Therapeutics Market Size for the Year 2017-2028
1.3 Crohn’s Disease Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Crohn’s Disease Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Crohn’s Disease Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Crohn’s Disease Therapeutics Market Dynamics
1.4.1 Crohn’s Disease Therapeutics Industry Trends
1.4.2 Crohn’s Disease Therapeutics Market Drivers
1.4.3 Crohn’s Disease Therapeutics Market Challenges
1.4.4 Crohn’s Disease Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Crohn’s Disease Therapeutics by Type
2.1 Crohn’s Disease Therapeutics Market Segment by Type
2.1.1 Non-Surgical
2.1.2 Surgical
2.2 Global Crohn’s Disease Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Crohn’s Disease Therapeutics Market Size by Type (2017-2028)
2.4 United States Crohn’s Disease Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Crohn’s Disease Therapeutics Market Size by Type (2017-2028)
3 Crohn’s Disease Therapeutics by Application
3.1 Crohn’s Disease Therapeutics Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.2 Global Crohn’s Disease Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Crohn’s Disease Therapeutics Market Size by Application (2017-2028)
3.4 United States Crohn’s Disease Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Crohn’s Disease Therapeutics Market Size by Application (2017-2028)
4 Global Crohn’s Disease Therapeutics Competitor Landscape by Company
4.1 Global Crohn’s Disease Therapeutics Market Size by Company
4.1.1 Top Global Crohn’s Disease Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Crohn’s Disease Therapeutics Revenue by Player (2017-2022)
4.2 Global Crohn’s Disease Therapeutics Concentration Ratio (CR)
4.2.1 Crohn’s Disease Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Crohn’s Disease Therapeutics in 2021
4.2.3 Global Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Crohn’s Disease Therapeutics Headquarters, Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Crohn’s Disease Therapeutics Headquarters and Area Served
4.3.2 Global Crohn’s Disease Therapeutics Companies Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Crohn’s Disease Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Crohn’s Disease Therapeutics Market Size by Company
4.5.1 Top Crohn’s Disease Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Crohn’s Disease Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Crohn’s Disease Therapeutics Market Size by Region
5.1 Global Crohn’s Disease Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Crohn’s Disease Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Crohn’s Disease Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Crohn’s Disease Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Crohn’s Disease Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Crohn’s Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Crohn’s Disease Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Crohn’s Disease Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Crohn’s Disease Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Crohn’s Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Crohn’s Disease Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Crohn’s Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Crohn’s Disease Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Crohn’s Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Johnson and Johnson Services Inc.
7.1.1 Johnson and Johnson Services Inc. Company Details
7.1.2 Johnson and Johnson Services Inc. Business Overview
7.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Introduction
7.1.4 Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.1.5 Johnson and Johnson Services Inc. Recent Development
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Company Details
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Introduction
7.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.2.5 Pfizer Inc. Recent Development
7.3 Allergan
7.3.1 Allergan Company Details
7.3.2 Allergan Business Overview
7.3.3 Allergan Crohn’s Disease Therapeutics Introduction
7.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.3.5 Allergan Recent Development
7.4 AbbVie Inc.
7.4.1 AbbVie Inc. Company Details
7.4.2 AbbVie Inc. Business Overview
7.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Introduction
7.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.4.5 AbbVie Inc. Recent Development
7.5 Takeda Pharmaceutical Company Limited
7.5.1 Takeda Pharmaceutical Company Limited Company Details
7.5.2 Takeda Pharmaceutical Company Limited Business Overview
7.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Introduction
7.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.5.5 Takeda Pharmaceutical Company Limited Recent Development
7.6 Celgene Corporation
7.6.1 Celgene Corporation Company Details
7.6.2 Celgene Corporation Business Overview
7.6.3 Celgene Corporation Crohn’s Disease Therapeutics Introduction
7.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.6.5 Celgene Corporation Recent Development
7.7 Perrigo Company PLC
7.7.1 Perrigo Company PLC Company Details
7.7.2 Perrigo Company PLC Business Overview
7.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Introduction
7.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.7.5 Perrigo Company PLC Recent Development
7.8 Ferring B.V.
7.8.1 Ferring B.V. Company Details
7.8.2 Ferring B.V. Business Overview
7.8.3 Ferring B.V. Crohn’s Disease Therapeutics Introduction
7.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.8.5 Ferring B.V. Recent Development
7.9 Salix Pharmaceuticals
7.9.1 Salix Pharmaceuticals Company Details
7.9.2 Salix Pharmaceuticals Business Overview
7.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Introduction
7.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.9.5 Salix Pharmaceuticals Recent Development
7.10 Gilead Sciences Inc.
7.10.1 Gilead Sciences Inc. Company Details
7.10.2 Gilead Sciences Inc. Business Overview
7.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Introduction
7.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.10.5 Gilead Sciences Inc. Recent Development
7.11 Genentech Inc.
7.11.1 Genentech Inc. Company Details
7.11.2 Genentech Inc. Business Overview
7.11.3 Genentech Inc. Crohn’s Disease Therapeutics Introduction
7.11.4 Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.11.5 Genentech Inc. Recent Development
7.12 UCB India Private Limited.
7.12.1 UCB India Private Limited. Company Details
7.12.2 UCB India Private Limited. Business Overview
7.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Introduction
7.12.4 UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
7.12.5 UCB India Private Limited. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Crohn’s Disease Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Crohn’s Disease Therapeutics Market Trends
Table 3. Crohn’s Disease Therapeutics Market Drivers
Table 4. Crohn’s Disease Therapeutics Market Challenges
Table 5. Crohn’s Disease Therapeutics Market Restraints
Table 6. Global Crohn’s Disease Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Crohn’s Disease Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Crohn’s Disease Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Crohn’s Disease Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Crohn’s Disease Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Crohn’s Disease Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Crohn’s Disease Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Crohn’s Disease Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Crohn’s Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2021)
Table 15. Top Players of Crohn’s Disease Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Crohn’s Disease Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Crohn’s Disease Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Crohn’s Disease Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Crohn’s Disease Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Crohn’s Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Crohn’s Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Crohn’s Disease Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Crohn’s Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Crohn’s Disease Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Crohn’s Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Crohn’s Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Crohn’s Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Johnson and Johnson Services Inc. Company Details
Table 31. Johnson and Johnson Services Inc. Business Overview
Table 32. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product
Table 33. Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Johnson and Johnson Services Inc. Recent Development
Table 35. Pfizer Inc. Company Details
Table 36. Pfizer Inc. Business Overview
Table 37. Pfizer Inc. Crohn’s Disease Therapeutics Product
Table 38. Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 39. Pfizer Inc. Recent Development
Table 40. Allergan Company Details
Table 41. Allergan Business Overview
Table 42. Allergan Crohn’s Disease Therapeutics Product
Table 43. Allergan Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Allergan Recent Development
Table 45. AbbVie Inc. Company Details
Table 46. AbbVie Inc. Business Overview
Table 47. AbbVie Inc. Crohn’s Disease Therapeutics Product
Table 48. AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 49. AbbVie Inc. Recent Development
Table 50. Takeda Pharmaceutical Company Limited Company Details
Table 51. Takeda Pharmaceutical Company Limited Business Overview
Table 52. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product
Table 53. Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Takeda Pharmaceutical Company Limited Recent Development
Table 55. Celgene Corporation Company Details
Table 56. Celgene Corporation Business Overview
Table 57. Celgene Corporation Crohn’s Disease Therapeutics Product
Table 58. Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Celgene Corporation Recent Development
Table 60. Perrigo Company PLC Company Details
Table 61. Perrigo Company PLC Business Overview
Table 62. Perrigo Company PLC Crohn’s Disease Therapeutics Product
Table 63. Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Perrigo Company PLC Recent Development
Table 65. Ferring B.V. Company Details
Table 66. Ferring B.V. Business Overview
Table 67. Ferring B.V. Crohn’s Disease Therapeutics Product
Table 68. Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Ferring B.V. Recent Development
Table 70. Salix Pharmaceuticals Company Details
Table 71. Salix Pharmaceuticals Business Overview
Table 72. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product
Table 73. Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Salix Pharmaceuticals Recent Development
Table 75. Gilead Sciences Inc. Company Details
Table 76. Gilead Sciences Inc. Business Overview
Table 77. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product
Table 78. Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Gilead Sciences Inc. Recent Development
Table 80. Genentech Inc. Company Details
Table 81. Genentech Inc. Business Overview
Table 82. Genentech Inc. Crohn’s Disease Therapeutics Product
Table 83. Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Genentech Inc. Recent Development
Table 85. UCB India Private Limited. Company Details
Table 86. UCB India Private Limited. Business Overview
Table 87. UCB India Private Limited. Crohn’s Disease Therapeutics Product
Table 88. UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 89. UCB India Private Limited. Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Crohn’s Disease Therapeutics Product Picture
Figure 2. Global Crohn’s Disease Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Crohn’s Disease Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Crohn’s Disease Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Crohn’s Disease Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Crohn’s Disease Therapeutics Market Share in Global 2017-2028
Figure 7. Crohn’s Disease Therapeutics Report Years Considered
Figure 8. Product Picture of Non-Surgical
Figure 9. Product Picture of Surgical
Figure 10. Global Crohn’s Disease Therapeutics Market Share by Type in 2022 & 2028
Figure 11. Global Crohn’s Disease Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Crohn’s Disease Therapeutics Market Share by Type (2017-2028)
Figure 13. United States Crohn’s Disease Therapeutics Market Share by Type in 2022 & 2028
Figure 14. United States Crohn’s Disease Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Crohn’s Disease Therapeutics Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospitals
Figure 17. Product Picture of Ambulatory Surgical Centers
Figure 18. Global Crohn’s Disease Therapeutics Market Share by Application in 2022 & 2028
Figure 19. Global Crohn’s Disease Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 20. Global Crohn’s Disease Therapeutics Market Share by Application (2017-2028)
Figure 21. United States Crohn’s Disease Therapeutics Market Share by Application in 2022 & 2028
Figure 22. United States Crohn’s Disease Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 23. United States Crohn’s Disease Therapeutics Market Share by Application (2017-2028)
Figure 24. North America Crohn’s Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 25. U.S. Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 26. Canada Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Europe Crohn’s Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. Germany Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. France Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. U.K. Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Italy Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Russia Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Crohn’s Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 34. China Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Japan Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. South Korea Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. India Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Australia Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Taiwan Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Indonesia Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Thailand Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Malaysia Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Philippines Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Latin America Crohn’s Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 45. Mexico Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Brazil Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Argentina Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Crohn’s Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Turkey Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Saudi Arabia Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. UAE Crohn’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Johnson and Johnson Services Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 53. Pfizer Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 54. Allergan Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 55. AbbVie Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 56. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 57. Celgene Corporation Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 58. Perrigo Company PLC Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 59. Ferring B.V. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 60. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 61. Gilead Sciences Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 62. Genentech Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 63. UCB India Private Limited. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson and Johnson Services Inc. Pfizer Inc. Allergan AbbVie Inc. Takeda Pharmaceutical Company Limited Celgene Corporation Perrigo Company PLC Ferring B.V. Salix Pharmaceuticals Gilead Sciences Inc. Genentech Inc. UCB India Private Limited.